[1] 林阳兴,曾华驱. 影像组学在肿瘤放射治疗中的应用研究[J].中国医疗器械信息,2024,30(8):44-46,144.
[2] 张裕辉,杨颖思,范伟雄,等. 基于多模态常规MRI的影像组学预测胶质瘤术后早期复发的价值[J].中国医学物理学杂志,2025,42(2):208-212.
[3] 张凤,蒲红. 影像学在肺结节诊断中的研究进展[J].实用医院临床杂志,2023,20(5):170-174.
[4] Shi Z, Zhang X, Jiang T.Study Progress of Radiomics in Precision Medicine for Lung Cancer[J]. Chinese Journal of Lung Cancer, 2019, 22(6): 385-388.
[5] 王少明,郑荣寿,韩冰峰,等. 2022年中国人群恶性肿瘤发病与死亡年龄特征分析[J].中国肿瘤,2024,33(3):165-174.
[6] Liu Q, Huang Y, Chen H, et al.Computed tomography-based radiomic features for diagnosis of indeterminate small pulmonary nodules[J]. J Comput Assist Tomogr, 2020, 44(1): 90-94.
[7] Zhang HF, Liao MY, Guo Q, et al.Predicting N2 lymph node metastasis in presurgical stage I-II non-small cell lung cancer using multiview radiomics and deep learning method[J]. Med Phys, 2023, 50(4): 2049-2060.
[8] 陈亮亮,陈基明,丁俊,等. CT影像组学特征预测非小细胞肺癌同步脑转移的价值[J].放射学实践,2022,37(4):419-425.
[9] Global cancer burden growing, amidst mounting need for services[J]. Saudi Med J, 2024, 45(3): 326-327.
[10] Loibl S, Poortmans P, Morrow M, et al.Breast Cancer[J]. Lancet, 2021, 397(10286): 1750-1769.
[11] The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of DiseaseStudy 2019[J]. The Lancet, 2022, 400(10352): 563-591.
[12] Zhang X, Wu S, Zu X, et al.Ultrasound-based radiomics nomogram for predicting HER2-low expression breast cancer[J]. Front Oncol, 2024, 14: 1438923.
[13] Xiong L, Chen H, Tang X, et al.Ultrasound-based radiomics analysis for predicting disease-free survival of invasive breast cancer[J]. Front Oncol, 2021, 11: 621993.
[14] Xu N, Zhou J, He X, et al.Radiomics model for evaluating the level of tumor-infiltrating lymphocytes in breast cancer based on dynamic contrast-enhanced MRI[J]. Clin Breast Cancer, 2021, 21(5): 440-449.
[15] 滕熠,张晓丹,夏昌发,等. 中国与全球癌症发病、死亡和患病对比及其预测分析:GLOBOCAN 2022数据解读[J]. 中华肿瘤防治杂志,2024,31(23):1413-1420.
[16] 李厚颖,宋歌声,李盼盼,等. 基于MRI多序列鉴别直肠隆起型腺癌及直肠腺瘤的研究[J]. 临床放射学杂志,2020,39(12):2471-2475.
[17] Maaref A, Romero FP, Montagnon E, et al.Predicting the response to FOLFOX-based chemotherapy regimen from untreated liver metastases on baseline CT: a deep neural network approach[J]. J Digit Imaging, 2020, 33(4): 937-945.
[18] 林礼波,陈晓丽,胥豪,等. 基于CT影像组学预测结直肠癌KRAS基因突变[J]. 中国医学影像学杂志,2023,31(6):617-621,629.
[19] Bray F, Laversanne M, Sung H, et al.Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263.
[20] Liu JZ, Dong L, Zhu YJ, et al.Prostate cancer treatment-China's perspective[J]. Cancer Lett, 2022, 550: 215927.
[21] Marvaso G, Isaksson LJ, Zaffaroni M, et al.Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models[J]. Eur Radiol, 2024, 34(10): 6241-6253.
[22] Sushentsev N, Rundo L, Blyuss O, et al.MRI-derived radiomics model for baseline prediction of prostate cancer progression on active surveillance[J]. Sci Rep, 2021, 11(1): 12917.
[23] Zhang GMY, Han YQ, Wei JW, et al.Radiomics Based on MRI as a Biomarker to Guide Therapy by Predicting Upgrading of Prostate Cancer From Biopsy to Radical Prostatectomy[J]. JMRI, 2020, 52(4): 1239-1248.
[24] 张希,杨雷,刘硕,等. 2022年全球恶性肿瘤统计报告解读[J]. 中华肿瘤杂志,2024,46(7):710-721.
[25] Ajani Jaffer A, D'Amico Thomas A, Bentrem David J, et al. Gastric cancer, version 2. 2022, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2022, 20(2): 167-192.
[26] He YY, Yang M, Hou R, et al.Preoperative prediction of perineural invasion and lymphovascular invasion with CT radiomics in gastric cancer[J]. European Journal of Radiology, 2024, 12: 100550.
[27] 赵福坤,董鹤翔,朱祥,等. CT对于进展期胃癌新辅助化疗疗效的预测价值[J].中国普外基础与临床杂志,2023,30(6):715-720.
[28] 原发性肝癌诊疗指南(2022年版)[J].肿瘤综合治疗电子杂志,2022,8(2):16-53.
[29] Guo L, Hao X, Chen L, et al.Early warning of hepatocellular carcinoma in cirrhotic patients by three-phase CT-based deep learning radiomics model: a retrospective, multicentre, cohort study[J]. EClinical Medicine, 2024, 74102718.
[30] Shi ZX, Li CF, Zhao LF, et al.Computed tomography radiomic features and clinical factors predicting the response to first transarterial chemoembolization in intermediate-stage hepatocellular carcinoma[J]. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 361-369. |
